Metraipolis › archive › dc_8d1a0ffef0ce

Complementary utility of plasma biomarkers and Aβ-PET for diagnosis, risk-stratification, and treatment monitoring in Alzheimer's disease — Europe PMC PMID:41088853

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41088853
DOI
10.1002/alz.70763
License (as archived)
solo-consultazione
Archived
2026-11-09T16:09:53.489Z
SHA-256 of the archived text
527935d4b6085b5fac4dc7807e91fca41ef5f59be3c1de014d61d8f652cf18d5
Stable URL of this page
https://metraipolis.com/documento/dc_8d1a0ffef0ce

How to cite

Complementary utility of plasma biomarkers and Aβ-PET for diagnosis, risk-stratification, and treatment monitoring in Alzheimer's disease — Europe PMC PMID:41088853 — Europe PMC (en), https://europepmc.org/article/MED/41088853 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8d1a0ffef0ce (Metraipolis archive dc_8d1a0ffef0ce, sha256 527935d4b6085b5fac4dc7807e91fca41ef5f59be3c1de014d61d8f652cf18d5)
BibTeX
@misc{dc8d1a0ffef0ce,
  title = {Complementary utility of plasma biomarkers and Aβ-PET for diagnosis, risk-stratification, and treatment monitoring in Alzheimer's disease — Europe PMC PMID:41088853},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41088853},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8d1a0ffef0ce; sha256 527935d4b6085b5fac4dc7807e91fca41ef5f59be3c1de014d61d8f652cf18d5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41088853. Agents can read the archived copy with the MCP tool read_document.